Response by Brass and Hiatt to Letter Regarding Article, "Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease"

Circulation. 2018 Mar 20;137(12):1304. doi: 10.1161/CIRCULATIONAHA.117.032707.

Authors

Eric P Brass¹, William R Hiatt²

Affiliations

¹ Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles (E.P.B.).
² Department of Medicine, Division of Cardiology, University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

PMID: 29555719
DOI: 10.1161/CIRCULATIONAHA.117.032707

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin*
Humans
Peripheral Arterial Disease*
Platelet Aggregation Inhibitors

Substances

Platelet Aggregation Inhibitors
Aspirin